ImmuPharma plc - Current Ratio
IMMPF
Price:
$0.085
Market Cap:
$19.86M
ImmuPharma plc, established in London, United Kingdom, in 1999, is a biopharmaceutical company dedicated to discovering and advancing peptide-based therapeutics. These treatments are focused on tackling conditions related to autoimmunity, inflammation, and various infections. The company's primary drug candidate, Lupuzor, an autophagy immunomodulator, is presently in Phase III clinical trials for the management of lupus, a chronic autoimmune inflammatory disorder. Additional product developments include BioAMB, a peptide-based medication for fungal infections, particularly those caused by the aspergillus family, and BioCin, a peptide-derived antibacterial agent designated for high medical ne...[Read more]
Industry
Biotechnology
IPO Date
2017-02-08
Stock Exchange
OTC
Ticker
IMMPF
PE Ratio
[-2.13]
ROE
[-1397.44%]
Current Ratio
[1.52]
Dividend Yield
[0%]
Enterprise Value
[18.50M]
Dividend History
The Current Ratio as of June 2026 (TTM) for ImmuPharma plc (IMMPF) is 1.52
According to ImmuPharma plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.52. This represents a change of 34.75% compared to the average of 1.13 of the last 4 quarters.
ImmuPharma plc (IMMPF) Historical Current Ratio (quarterly & annually)
How has IMMPF Current Ratio performed in the past?
The mean historical Current Ratio of ImmuPharma plc over the last ten years is 3.54. The current 1.52 Current Ratio has changed 4.20% with respect to the historical average. Over the past ten years (40 quarters), IMMPF's Current Ratio was at its highest in in the March 2018 quarter at 11.64. The Current Ratio was at its lowest in in the September 2024 quarter at 0.58.
Average
3.54
Median
2.99
Minimum
0.58
Maximum
6.73
ImmuPharma plc (IMMPF) Current Ratio by Quarter and Year
Discovering the peaks and valleys of ImmuPharma plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 225.48%
Maximum Annual Current Ratio = 6.73
Minimum Annual Increase = -64.15%
Minimum Annual Current Ratio = 0.58
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 1.52 | 161.43% |
| 2024 | 0.58 | -27.83% |
| 2023 | 0.81 | -49.95% |
| 2022 | 1.61 | -23.69% |
| 2021 | 2.11 | -64.15% |
| 2020 | 5.89 | -12.52% |
| 2019 | 6.73 | 13.41% |
| 2018 | 5.94 | 53.33% |
| 2017 | 3.87 | -38.72% |
| 2016 | 6.32 | 225.48% |
ImmuPharma plc (IMMPF) Average Current Ratio
How has IMMPF Current Ratio performed in the past?
The current Current Ratio of ImmuPharma plc (IMMPF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
0.97
5-year avg
1.33
10-year avg
3.54
ImmuPharma plc (IMMPF) Current Ratio vs. Peers
How is IMMPF’s Current Ratio compared to its peers?
ImmuPharma plc’s Current Ratio is greater than IntelGenx Technologies Corp. (0.41), greater than LakeShore Biopharma Co., Ltd (1.02), less than IBEX Technologies Inc. (5.69), greater than OKYO Pharma Limited (0.58), greater than Kadimastem Ltd (0.02), greater than Alpha Cognition Inc. (0.73), less than Small Pharma Inc. (5.77), greater than Organicell Regenerative Medicine, Inc. (1.05), greater than Generation Hemp, Inc. (0.16), greater than Chill Brands Group PLC (0.87),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.41 | $29.69M | |
| 1.02 | $2.76M | |
| 5.69 | $25.27M | |
| 0.58 | $22.73M | |
| 0.02 | $9.50M | |
| 0.73 | $35.66M | |
| 5.77 | $37.51M | |
| 1.05 | $19.97M | |
| 0.16 | $25.34M | |
| 0.87 | $24.45M |
Build a custom stock screener for ImmuPharma plc (IMMPF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuPharma plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
ImmuPharma plc (IMMPF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like ImmuPharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is ImmuPharma plc's Current Ratio?
How is the Current Ratio calculated for ImmuPharma plc (IMMPF)?
What is the highest Current Ratio for ImmuPharma plc (IMMPF)?
What is the 3-year average Current Ratio for ImmuPharma plc (IMMPF)?
What is the 5-year average Current Ratio for ImmuPharma plc (IMMPF)?
How does the current Current Ratio for ImmuPharma plc (IMMPF) compare to its historical average?